Brief: Biohit: GastroPanel Validated As Predictor Of Gastric Cancer Risk In Multicenter Study
April 9 (Reuters) - Biohit Oyj BIOBV.HE :
* BIOHIT GASTROPANEL® BIOMARKERS VALIDATED AS POWERFUL
PREDICTORS
OF GASTRIC CANCER RISK IN A MULTICENTER STUDY
Source text for Eikon: ID:nGNE33CTNt
Further company coverage: BIOBV.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))